iVeena

iVeena

Pharmaceutical Manufacturing Salt Lake City, Utah, United States 8 employees
Employees
8
Contacts
4
Emails
4
Phones
2

iVeena Overview

Headquarters
Salt Lake City, Utah, United States
Website
iveenamed.com
Industry
Pharmaceutical Manufacturing
Employees
8
Funding
3.0M
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
Keywords

About iVeena

iVeena Delivery Systems, Inc. is a privately held, clinical stage ophthalmology company developing disease-modifying pharmacologic innovations for refractive diseases. iVeena has licensed its lead asset to Glaukos Corporation, IVMED-80, an Orphan Drug Designated eye drop for keratoconus. iVeena is developing IVMED-85, a first-in-class, investigational eyedrop formulation for pediatric myopia. The company’s lead programs comprise of novel proprietary products; IVMED-80 for keratoconus and IVMED-85 for myopia.

iVeena Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

iVeena Org Chart

Sample employees and titles
Name Title Contact
Robert Dempsey Chief Executive Officer - Board
Email Phone
Ron Heffernan Partner at Impact Capital Partner, Llc
Email Phone
David G. Hunter Ophthalmologist-in Chief and Professor
Email
Mike Burr Vice President Product Development
Email

Employees by Management Level

Executive 3 profiles
Individual contributor 1 profile

Department Contact Coverage

Department Contacts Email Phone
Executive 1 1 0

Compare Similar Companies to iVeena